Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB) (Bangabandhu)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2012 by Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Dr. Mamun-Al-Mahtab, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
ClinicalTrials.gov Identifier:
NCT01589952
First received: May 1, 2012
Last updated: NA
Last verified: May 2012
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2013
  Estimated Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)